The proliferation index of circulating tumor cells (CTCs) is not influenced by the administration of adjuvant chemotherapy in early breast cancer (BC) and seems to reflect Ki67 expression of the primary tumor

被引：0
|
作者：
Agelaki, S.
Spiliotaki, M.
Spanaki, A.
Kassiou, L.
Tzardi, M.
Koinis, F.
Kafousi, M.
Georgoulias, V.
Mavroudis, D.
机构：
[1] Univ Crete, Sch Med, Tumor Cell Biol Lab, Iraklion, Greece
[2] Univ Gen Hosp Heraklion, Iraklion, Greece
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P2-02-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-02-16
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Trastuzumab in HER2-negative early breast cancer as adjuvant treatment for circulating tumor cells (CTCs) (Treat CTC)
    Ignatiadis, Michail
    Messina, Carlo
    Litiere, Saskia
    Mavroudis, Dimitris
    Dittrich, Christian
    Kong, Anthony
    Janni, Wolfgang
    Sotiriou, Christos
    Piccart, Martine
    Pierga, Jean-Yves
    Rack, Brigitte
    CANCER RESEARCH, 2015, 75
  • [42] Circulating tumor cells (CTCs) and epithelial mesenchymal transition (EMT) in primary breast cancer.
    Karaba, Marian
    Mego, Michal
    Minarik, Gabriel
    Benca, Juraj
    Sedlackova, Tatiana
    Manasova, Denisa
    Sieberova, Gabriela
    Hlavata, Zuzana
    Jurik, Andrej
    Minarik, Tomas
    Macuch, Jan
    Gronesova, Paulina
    Oravcova, Eva
    Svabova, Veronika
    Sufliarsky, Jozef
    Pechan, Juraj
    Reuben, James A.
    Mardiak, Jozef
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] Distinct clinical and biological values of subpopulations of circulating tumor cells (CTCs) in primary breast cancer
    Mego, M.
    Jurisova, S.
    Karaba, M.
    Minarik, G.
    Benca, J.
    Sedlackova, T.
    Manasova, D.
    Malejcikova, M.
    Sieberova, G.
    Macuch, J.
    Gronesova, P.
    Sufliarsky, J.
    Pindak, D.
    Cristofanilli, M.
    Reuben, J. N.
    Mardiak, J.
    CANCER RESEARCH, 2016, 76
  • [44] HER2-positive circulating tumor cells (CTCs) in advanced breast cancer (BC): A feature independent of BC subtype
    Shah, A. N.
    Gerratana, L.
    Davis, A. A.
    Zhang, Q.
    Zhang, Y.
    Rossi, G.
    Wang, C.
    Strickland, K.
    Yang, H.
    Flaum, L.
    Abu-Khalaf, M.
    Behdad, A.
    Ye, Z.
    Platanias, L.
    Gradishar, W. J.
    Cristofanilli, M.
    CANCER RESEARCH, 2019, 79 (04)
  • [45] CIRCULATING TUMOR CELLS (CTCS) IN PERIPHERAL BLOOD OF BREAST CANCER PATIENTS BEFORE AND AFTER ADJUVANT CHEMOTHERAPY THE GERMAN SUCCESS-TRIAL
    Rack, B.
    Schindlbeck, C.
    Schneeweiss, A.
    Hilfrich, J.
    Lorenz, R.
    Jueckstock, J.
    Beckmann, M.
    Pantel, K.
    Lichtenegger, W.
    Sommer, H.
    Friese, K.
    Janni, W.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4048 - 4049
  • [46] Proliferation Determined by ki67 Marker and pCR in Locally Advanced Breast Cancer Patients Treated with Neo-adjuvant Chemotherapy
    Sanchez-Munoz, Alfonso
    Plata-Fernandez, Yessica
    Jaen, Ana
    Lomas, Maria
    Fernandez, Margarita
    Llacer, Casilda
    Fernandez, Monica
    Ribelles, Nuria
    Alba, Emilio
    Sanchez-Rovira, Pedro
    BREAST JOURNAL, 2013, 19 (06): : 685 - 686
  • [47] Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
    Horimoto, Yoshiya
    Arakawa, Atsushi
    Tanabe, Masahiko
    Sonoue, Hiroshi
    Igari, Fumie
    Senuma, Koji
    Tokuda, Emi
    Shimizu, Hideo
    Kosaka, Taijiro
    Saito, Mitsue
    BMC CANCER, 2014, 14 : 550
  • [48] Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
    Yoshiya Horimoto
    Atsushi Arakawa
    Masahiko Tanabe
    Hiroshi Sonoue
    Fumie Igari
    Koji Senuma
    Emi Tokuda
    Hideo Shimizu
    Taijiro Kosaka
    Mitsue Saito
    BMC Cancer, 14
  • [49] The prevalence and quantity of circulating tumor cells (CTCs) after adjuvant chemotherapy with and without anthracyclines in patients with HER2-negative early breast cancer (EBC)
    Schochter, F.
    Andergassen, U.
    Neugebauer, J. K.
    Friedl, T. W. P.
    Pestka, A.
    Jueckstock, J. K.
    Jaeger, B.
    Salmen, J. C.
    Hepp, P. G. M.
    Heinrich, G.
    Camara, O.
    Decker, T.
    Ober, A.
    Fehm, T. N.
    Pantel, K.
    Fasching, P. A.
    Schneeweis, A.
    Beckmann, M. W.
    Janni, W.
    Rack, B. K.
    CANCER RESEARCH, 2013, 73
  • [50] Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer
    A Bottini
    A Berruti
    A Bersiga
    M P Brizzi
    P Bruzzi
    S Aguggini
    A Brunelli
    G Bolsi
    G Allevi
    D Generali
    E Betri
    G Bertoli
    P Alquati
    L Dogliotti
    British Journal of Cancer, 2001, 85 : 1106 - 1112
12345